Medications for Emphysema

12 results

  • glassia

    (ALPHA.1-PROTEINASE INHIBITOR HUMAN)
    Takeda Pharmaceuticals America, Inc.
    GLASSIA is indicated for chronic augmentation and maintenance therapy in individuals with emphysema due to severe hereditary Alpha-1 Proteinase Inhibitor deficiency (AAT deficiency). Its effects on pulmonary exacerbations and emphysema progression are not conclusively demonstrated. It is not for use in patients without established severe deficiency.

  • ipratropium bromide

    (Ipratropium Bromide)
    A-S Medication Solutions
    Ipratropium Bromide Inhalation Solution is indicated for maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and can be used alone or with other bronchodilators, particularly beta adrenergics.

  • prolastin-c liquid

    (Alpha1-Proteinase Inhibitor (Human))
    GRIFOLS USA, LLC
    PROLASTIN-C LIQUID is indicated for chronic augmentation and maintenance therapy in adults with emphysema due to severe hereditary Alpha-1 Proteinase Inhibitor deficiency. Its effects on pulmonary exacerbations and emphysema progression are not conclusively demonstrated, and it is not for use without established deficiency.

  • terbutaline sulfate

    (Terbutaline Sulfate)
    ANI Pharmaceuticals Inc
    Terbutaline Sulfate Tablets USP are indicated for preventing and reversing bronchospasm in patients aged 12 years and older with asthma and reversible bronchospasm related to bronchitis and emphysema.

  • terbutaline sulfate

    (Terbutaline Sulfate)
    Henry Schein, Inc.
    Terbutaline Sulfate Injection is indicated for preventing and reversing bronchospasm in patients aged 12 and older with asthma and reversible bronchospasm linked to bronchitis and emphysema.

  • terbutaline sulfate

    (TERBUTALINE SULFATE)
    Areva Pharmaceuticals
    Terbutaline sulfate injection is indicated for preventing and reversing bronchospasm in patients aged 12 and older with asthma, as well as reversible bronchospasm associated with bronchitis and emphysema.

  • terbutaline sulfate

    (Terbutaline Sulfate)
    Bora Pharmaceutical Laboratories Inc.
    Terbutaline sulfate is indicated for preventing and reversing bronchospasm in patients aged 12 and older with asthma, as well as reversible bronchospasm associated with bronchitis and emphysema.

  • theophylline

    (Theophylline)
    Ajanta Pharma USA Inc.
    Theophylline extended-release tablets are indicated for treating symptoms and reversible airflow obstruction in chronic asthma and other chronic lung diseases such as emphysema and chronic bronchitis.

  • theophylline

    (Theophylline)
    Alembic Pharmaceuticals Limited
    Theophylline extended-release tablets are indicated for treating symptoms and reversible airflow obstruction in chronic asthma and other lung diseases, such as emphysema and chronic bronchitis.

  • theophylline

    (Theophylline)
    Harman Finochem Limited
    Theophylline extended-release tablets are indicated for treating symptoms and reversible airflow obstruction in chronic asthma, emphysema, and chronic bronchitis.